Safrole

Last updated
Safrole [1]
Safrole-Line-Structure.png
Safrole-3D-balls.png
Names
Preferred IUPAC name
5-(Prop-2-en-1-yl)-2H-1,3-benzodioxole
Other names
5-(2-Propenyl)-1,3-benzodioxole
5-Allylbenzo[d][1,3]dioxole
3,4-Methylenedioxyphenyl-2-propene
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard 100.002.133 OOjs UI icon edit-ltr-progressive.svg
EC Number
  • 202-345-4
KEGG
PubChem CID
RTECS number
  • CY2800000
UNII
UN number 3082
  • InChI=1S/C10H10O2/c1-2-3-8-4-5-9-10(6-8)12-7-11-9/h2,4-6H,1,3,7H2 Yes check.svgY
    Key: ZMQAAUBTXCXRIC-UHFFFAOYSA-N Yes check.svgY
  • InChI=1/C10H10O2/c1-2-3-8-4-5-9-10(6-8)12-7-11-9/h2,4-6H,1,3,7H2
    Key: ZMQAAUBTXCXRIC-UHFFFAOYAD
  • C=CCc1ccc2OCOc2c1
Properties
C10H10O2
Molar mass 162.188 g·mol−1
Density 1.096 g/cm3
Melting point 11 °C (52 °F; 284 K)
Boiling point 232 to 234 °C (450 to 453 °F; 505 to 507 K)
−97.5×10−6 cm3/mol
Hazards
GHS labelling:
GHS-pictogram-exclam.svg GHS-pictogram-silhouette.svg
Danger
H302, H341, H350
P201, P281, P308+P313
Legal status
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)

Safrole is an organic compound with the formula CH2O2C6H3CH2CH=CH2. It is a colorless oily liquid, although impure samples can appear yellow. A member of the phenylpropanoid family of natural products, it is found in sassafras plants, among others. Small amounts are found in a wide variety of plants, where it functions as a natural antifeedant. [3] Ocotea pretiosa , [4] which grows in Brazil, and Sassafras albidum , [3] which grows in eastern North America, are the main natural sources of safrole. It has a characteristic "sweet-shop" aroma.

Contents

It is a precursor in the synthesis of the insecticide synergist piperonyl butoxide, the fragrance piperonal via isosafrole, and the empathogenic/entactogenic substance MDMA.

History

Safrole was obtained from a number of plants, but especially from the sassafras tree ( Sassafras albidum ), which is native to North America, and from Japanese star anise ( Illicium anisatum , called shikimi in Japan). [5] In 1844, the French chemist Édouard Saint-Èvre (1817-1879) [6] determined safrole's empirical formula. [7] In 1869, the French chemists Édouard Grimaux (1835–1900) and J. Ruotte investigated and named safrole. [8] They observed its reaction with bromine, suggesting the presence of an allyl group. [9] By 1884, the German chemist Theodor Poleck (1821–1906) suggested that safrole was a derivative of benzene, to which two oxygen atoms were joined as epoxides (cyclic ethers). [10]

In 1885, the Dutch chemist Johann Frederik Eijkman (1851–1915) investigated shikimol, the essential oil that is obtained from Japanese star anise, and he found that, upon oxidation, shikimol formed piperonylic acid, [11] whose basic structure had been determined in 1871 by the German chemist Wilhelm Rudolph Fittig (1835–1910) and his student, the American chemist Ira Remsen (1846–1927). [12] Thus Eijkman inferred the correct basic structure for shikimol. [13] He also noted that shikimol and safrole had the same empirical formula and had other similar properties, and thus he suggested that they were probably identical. [14] In 1886, Poleck showed that upon oxidation, safrole also formed piperonylic acid, and thus shikimol and safrole were indeed identical. [15] It remained to be determined whether the molecule's C3H5 group was a propenyl group (R−CH=CH−CH3) or an allyl group (R−CH2−CH=CH2). In 1888, the German chemist Julius Wilhelm Brühl (1850–1911) determined that the C3H5 group was an allyl group. [16]

Natural occurrence

Safrole is the principal component of brown camphor oil made from Ocotea pretiosa , [4] a plant growing in Brazil, and sassafras oil made from Sassafras albidum .

In the US, commercially available culinary sassafras oil is usually devoid of safrole due to a rule passed by the U.S. FDA in 1960. [17]

Safrole can be obtained through natural extraction from Sassafras albidum and Ocotea cymbarum . Sassafras oil for example is obtained by steam distillation of the root bark of the sassafras tree. The resulting steam distilled product contains about 90% safrole by weight. The oil is dried by mixing it with a small amount of anhydrous calcium chloride. After filtering-off the calcium chloride, the oil is vacuum distilled at 100 °C under a vacuum of 11 mmHg (1.5 kPa) or frozen to crystallize the safrole out. This technique works with other oils in which safrole is present as well. [18] [19]

Safrole is typically extracted from the root-bark or the fruit of Sassafras albidum [20] (native to eastern North America) in the form of sassafras oil, or from Ocotea odorifera , [21] a Brazilian species. Safrole is also present in certain essentials oils and in brown camphor oil, which is present in small amounts in many plants. Safrole can be found in anise, nutmeg, cinnamon, and black pepper. Safrole can be detected in undiluted liquid beverages and pharmaceutical preparations by high-performance liquid chromatography. [22]

Applications

Safrole is a member of the methylenedioxybenzene group, of which many compounds are used as insecticide synergists; for example, safrole is used as a precursor in the synthesis of the insecticide piperonyl butoxide. Safrole is also used as a precursor in the synthesis of the drug ecstasy (MDMA, 3,4-methylenedioxymethamphetamine). Before safrole was banned by the US FDA in 1960 for use in food, it was used as a food flavor for its characteristic ‘candy-shop’ aroma. It was used as an additive in root beer, chewing gum, toothpaste, soaps, and certain pharmaceutical preparations.

Safrole exhibits antibiotic [23] and anti-angiogenic [24] functions.

Synthesis

It can be synthesized from catechol [25] first by conversion to methylenedioxybenzene, which is brominated and coupled with allyl bromide. [26]

Safrole is a versatile precursor to many compounds. Examples are N-acylarylhydrazones, isosters, [27] aryl-sulfonamide derivatives, [28] acidic sulfonylhydrazone derivatives, [29] benzothiazine derivatives. [30] and many more.

Isosafrole

Isosafrole is produced synthetically from safrole. It is not found in nature. Isosafrole comes in two forms, trans-isosafrole and cis-isosafrole. Isosafrole is used as a precursor for the psychoactive drug MDMA (ecstasy). When safrole is metabolized several metabolites can be identified. Some of these metabolites have been shown to exhibit toxicological effects, such as 1′-hydroxysafrole and 3′-hydroxysafrole in rats. Further metabolites of safrole that have been found in urine of both rats and humans include 1,2-dihydroxy-4-allylbenzene or 1(2)-methoxy-2(1)hydroxy-4-allylbenzene. [31]

Metabolism

Safrole can undergo many forms of metabolism. The two major routes are the oxidation of the allyl side chain and the oxidation of the methylenedioxy group. [32] The oxidation of the allyl side chain is mediated by a cytochrome P450 complex, which will transform safrole into 1′-hydroxysafrole. The newly formed 1′-hydroxysafrole will undergo a phase II drug metabolism reaction with a sulfotransferase enzyme to create 1′-sulfoxysafrole, which can cause DNA adducts. [33] A different oxidation pathway of the allyl side chain can form safrole epoxide. So far, this has only been found in rats and guinea pigs. The formed epoxide is a small metabolite due to the slow formation and further metabolism of the compound. An epoxide hydratase enzyme will act on the epoxide to form dihydrodiol, which can be secreted in urine.

The metabolism of safrole through the oxidation of the methylenedioxy proceeds via the cleavage of the methylenedioxy group. This results in two major metabolites: allylcatechol and its isomer, propenylcatechol. Eugenol is a minor metabolite of safrole in humans, mice, and rats. The intact allyl side chain of allylcatechol may then be oxidized to yield 2′,3′-epoxypropylcatechol. This can serve as a substrate for an epoxide hydratase enzyme, and will hydrate the 2′,3′-epoxypropylcatechol to 2′,3′-dihydroxypropylcatechol. This new compound can be oxidized to form propionic acid (PPA), [32] which is a substance that is related to an increase in oxidative stress and glutathione S-transferase activity. PPA also causes a decrease in glutathione and Glutathione peroxidase activity. [34] The epoxide of allylcatechol may also be generated from the cleavage of the methylenedioxy group of the safrole epoxide. The cleavage of the methylenedioxy ring and the metabolism of the allyl group involve hepatic microsomal mixed-function oxidases. [32]

Toxicity

Toxicological studies have shown that safrole is a weak hepatocarcinogen at higher doses in rats and mice. Safrole requires metabolic activation before exhibiting toxicological effects. [32] Metabolic conversion of the allyl group in safrole is able to produce intermediates which are directly capable of binding covalently with DNA and proteins. Metabolism of the methylenedioxy group to a carbene allows the molecule to form ligand complexes with cytochrome P450 and P448. The formation of this complex leads to lower amounts of available free cytochrome P450. Safrole can also directly bind to cytochrome P450, leading to competitive inhibition. These two mechanisms result in lowered mixed function oxidase activity.

Furthermore, because of the altered structural and functional properties of cytochrome P450, loss of ribosomes which are attached to the endoplasmatic reticulum through cytochrome P450 may occur. [31] The allyl group thus directly contributes to mutagenicity, while the methylenedioxy group is associated with changes in the cytochrome P450 system and epigenetic aspects of carcinogenicity. [31] In rats, safrole and related compounds produced both benign and malignant tumors after intake through the mouth. Changes in the liver are also observed through the enlargement of liver cells and cell death.

In the United States, it was once widely used as a food additive in root beer, sassafras tea, and other common goods, but was banned for human consumption by the FDA after studies in the 1960s suggested that safrole was carcinogenic, causing permanent liver damage in rats; [35] [36] [37] food products sold there purporting to contain sassafras instead contain a safrole-free sassafras extract. Safrole is also banned for use in soap and perfumes by the International Fragrance Association.

According to a 1977 study of the metabolites of safrole in both rats and humans, two carcinogenic metabolites of safrole found in the urine of rats, 1′-hydroxysafrole and 3′-hydroxyisosafrole, were not found in human urine. [38] The European Commission on Health and consumer protection assumes safrole to be genotoxic and carcinogenic. [39] It occurs naturally in a variety of spices, such as cinnamon, nutmeg, and black pepper, and herbs such as basil. In that role, safrole, like many naturally-occurring compounds, may have a small but measurable ability to induce cancer in rodents. Despite this, the effects in humans were estimated by the Lawrence Berkeley National Laboratory to be similar to risks posed by breathing indoor air or drinking municipally supplied water. [40]

Adverse effects

Besides being a hepatocarcinogen, safrole exhibits further adverse effects in that it will induce the formation of hepatic lipid hydroperoxides. [41] Safrole also inhibits the defensive function of neutrophils against bacteria. In addition to the inhibition of the defensive function of neutrophils, it has also been discovered that safrole interferes with the formation of superoxides by neutrophils. [23] Furthermore, safrole oxide, a metabolite of safrole, has a negative effect on the central nervous system. Safrole oxide inhibits the expression of integrin β4/SOD, which leads to apoptosis of the nerve cells. [42]

Use in MDMA manufacture

MDMA synthesis from safrole MDA from safrole en.png
MDMA synthesis from safrole

Safrole is listed as a Table I precursor under the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. [43] Due to their role in the manufacture of MDMA, safrole, isosafrole, and piperonal are Category I precursors under regulation no. 273/2004 of the European Community. [44] In the United States, safrole is currently a List I chemical.

The root bark of American sassafras contains a low percentage of steam-volatile oil, which is typically 75% safrole. [45] Attempts to refine safrole from sassafras bark in mass quantities are generally not economically viable due to low yield and high effort. However, smaller quantities can be extracted quite easily via steam distillation (about 10% of dry sassafras root bark by mass, or about 2% of fresh bark). [46] Demand for safrole is causing rapid and illicit harvesting of the Cinnamomum parthenoxylon tree in Southeast Asia, in particular the Cardamom Mountains in Cambodia. [47] However, it is not clear what proportion of illicitly harvested safrole is going toward MDMA production, as over 90% of the global safrole supply (about 2,000 tonnes or 2,200 short tons per year) is used to manufacture pesticides, fragrances, and other chemicals. [48] [49] Sustainable harvesting of safrole is possible from leaves and stems of certain plants, including the roots of camphor seedlings. [48] [49]

See also

Related Research Articles

<i>Sassafras</i> Genus of trees

Sassafras is a genus of three extant and one extinct species of deciduous trees in the family Lauraceae, native to eastern North America and eastern Asia. The genus is distinguished by its aromatic properties, which have made the tree useful to humans.

<span class="mw-page-title-main">Myristicin</span> Chemical compound

Myristicin is a naturally occurring compound found in common herbs and spices, such as nutmeg. It is an insecticide, and has been shown to enhance the effectiveness of other insecticides.

<span class="mw-page-title-main">Cytochrome P450</span> Class of enzymes

Cytochromes P450 are a superfamily of enzymes containing heme as a cofactor that mostly, but not exclusively, function as monooxygenases. In mammals, these proteins oxidize steroids, fatty acids, and xenobiotics, and are important for the clearance of various compounds, as well as for hormone synthesis and breakdown. In 1963, Estabrook, Cooper, and Rosenthal described the role of CYP as a catalyst in steroid hormone synthesis and drug metabolism. In plants, these proteins are important for the biosynthesis of defensive compounds, fatty acids, and hormones.

Benzo(<i>a</i>)pyrene Carcinogenic compound found in smoke and soot

Benzo[a]pyrene (BaP or B[a]P) is a polycyclic aromatic hydrocarbon and the result of incomplete combustion of organic matter at temperatures between 300 °C (572 °F) and 600 °C (1,112 °F). The ubiquitous compound can be found in coal tar, tobacco smoke and many foods, especially grilled meats. The substance with the formula C20H12 is one of the benzopyrenes, formed by a benzene ring fused to pyrene. Its diol epoxide metabolites (more commonly known as BPDE) react with and bind to DNA, resulting in mutations and eventually cancer. It is listed as a Group 1 carcinogen by the IARC. In the 18th century a scrotal cancer of chimney sweepers, the chimney sweeps' carcinoma, was already known to be connected to soot.

<span class="mw-page-title-main">Methylcholanthrene</span> Chemical compound

Methylcholanthrene is a highly carcinogenic polycyclic aromatic hydrocarbon produced by burning organic compounds at very high temperatures. Methylcholanthrene is also known as 3-methylcholanthrene, 20-methylcholanthrene or the IUPAC name 3-methyl-1,2-dyhydrobenzo[j]aceanthrylene. The short notation often used is 3-MC or MCA. This compound forms pale yellow solid crystals when crystallized from benzene and ether. It has a melting point around 180 °C and its boiling point is around 280 °C at a pressure of 80 mmHg. Methylcholanthrene is used in laboratory studies of chemical carcinogenesis. It is an alkylated derivative of benz[a]anthracene and has a similar UV spectrum. The most common isomer is 3-methylcholanthrene, although the methyl group can occur in other places.

<span class="mw-page-title-main">CYP2E1</span> Protein-coding gene in the species Homo sapiens

Cytochrome P450 2E1 is a member of the cytochrome P450 mixed-function oxidase system, which is involved in the metabolism of xenobiotics in the body. This class of enzymes is divided up into a number of subcategories, including CYP1, CYP2, and CYP3, which as a group are largely responsible for the breakdown of foreign compounds in mammals.

Drug metabolism is the metabolic breakdown of drugs by living organisms, usually through specialized enzymatic systems. More generally, xenobiotic metabolism is the set of metabolic pathways that modify the chemical structure of xenobiotics, which are compounds foreign to an organism's normal biochemistry, such as any drug or poison. These pathways are a form of biotransformation present in all major groups of organisms and are considered to be of ancient origin. These reactions often act to detoxify poisonous compounds. The study of drug metabolism is called pharmacokinetics.

Toxication, toxification or toxicity exaltation is the conversion of a chemical compound into a more toxic form in living organisms or in substrates such as soil or water. The conversion can be caused by enzymatic metabolism in the organisms, as well as by abiotic chemical reactions. While the parent drug are usually less active, both the parent drug and its metabolite can be chemically active and cause toxicity, leading to mutagenesis, teratogenesis, and carcinogenesis. Different classes of enzymes, such as P450-monooxygenases, epoxide hydrolase, or acetyltransferases can catalyze the process in the cell, mostly in the liver.

<span class="mw-page-title-main">Sudan I</span> Chemical compound

Sudan I is an organic compound, typically classified as an azo dye. It is an intensely orange-red solid that is added to colourise waxes, oils, petrol, solvents, and polishes. Sudan I has also been adopted for colouring various foodstuffs, especially curry powder and chili powder, although the use of Sudan I in foods is now banned in many countries, because Sudan I, Sudan III, and Sudan IV have been classified as category 3 carcinogens by the International Agency for Research on Cancer. Sudan I is still used in some orange-coloured smoke formulations and as a colouring for cotton refuse used in chemistry experiments.

<span class="mw-page-title-main">CYP1A2</span> Enzyme in the human body

Cytochrome P450 1A2, a member of the cytochrome P450 mixed-function oxidase system, is involved in the metabolism of xenobiotics in the human body. In humans, the CYP1A2 enzyme is encoded by the CYP1A2 gene.

<span class="mw-page-title-main">CYP1A1</span> Protein-coding gene in the species Homo sapiens

Cytochrome P450, family 1, subfamily A, polypeptide 1 is a protein that in humans is encoded by the CYP1A1 gene. The protein is a member of the cytochrome P450 superfamily of enzymes.

<i>Sassafras albidum</i> Species of plant

Sassafras albidum is a species of Sassafras native to eastern North America, from southern Maine and southern Ontario west to Iowa, and south to central Florida and eastern Texas. It occurs throughout the eastern deciduous forest habitat type, at altitudes of up to 1,500 m (4,900 ft) above sea level. It formerly also occurred in southern Wisconsin, but is extirpated there as a native tree.

<i>o</i>-Toluidine Aryl amine

o-Toluidine (ortho-toluidine) is an organic compound with the chemical formula CH3C6H4NH2. It is the most important of the three isomeric toluidines. It is a colorless liquid although commercial samples are often yellowish. It is a precursor to the herbicides metolachlor and acetochlor.

<span class="mw-page-title-main">CYP2C18</span> Protein-coding gene in the species Homo sapiens

Cytochrome P450 2C18 is a protein that in humans is encoded by the CYP2C18 gene.

Epoxygenases are a set of membrane-bound, heme-containing cytochrome P450 enzymes that metabolize polyunsaturated fatty acids to epoxide products that have a range of biological activities. The most thoroughly studied substrate of the CYP epoxylgenases is arachidonic acid. This polyunsaturated fatty acid is metabolized by cyclooxygenases to various prostaglandin, thromboxane, and prostacyclin metabolites in what has been termed the first pathway of eicosanoid production; it is also metabolized by various lipoxygenases to hydroxyeicosatetraenoic acids and leukotrienes in what has been termed the second pathway of eicosanoid production. The metabolism of arachidonic acid to epoxyeicosatrienoic acids by the CYP epoxygenases has been termed the third pathway of eicosanoid metabolism. Like the first two pathways of eicosanoid production, this third pathway acts as a signaling pathway wherein a set of enzymes metabolize arachidonic acid to a set of products that act as secondary signals to work in activating their parent or nearby cells and thereby orchestrate functional responses. However, none of these three pathways is limited to metabolizing arachidonic acid to eicosanoids. Rather, they also metabolize other polyunsaturated fatty acids to products that are structurally analogous to the eicosanoids but often have different bioactivity profiles. This is particularly true for the CYP epoxygenases which in general act on a broader range of polyunsaturated fatty acids to form a broader range of metabolites than the first and second pathways of eicosanoid production. Furthermore, the latter pathways form metabolites many of which act on cells by binding with and thereby activating specific and well-characterized receptor proteins; no such receptors have been fully characterized for the epoxide metabolites. Finally, there are relatively few metabolite-forming lipoxygenases and cyclooxygenases in the first and second pathways and these oxygenase enzymes share similarity between humans and other mammalian animal models. The third pathway consists of a large number of metabolite-forming CYP epoxygenases and the human epoxygenases have important differences from those of animal models. Partly because of these differences, it has been difficult to define clear roles for the epoxygenase-epoxide pathways in human physiology and pathology.

<span class="mw-page-title-main">3',4'-Methylenedioxy-α-pyrrolidinopropiophenone</span> Stimulant drug

3',4'-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) is a stimulant designer drug. It was sold in Germany in the late 1990s and early 2000s as an ingredient in imitation ecstasy (MDMA) pills. It shares a similar chemical structure with α-PPP and MDPV, and has been shown to have reinforcing effects in rats.

<span class="mw-page-title-main">Diepoxybutane</span> Chemical compound

Diepoxybutane is an epoxide which is a colorless liquid at room temperature. It is therefore highly reactive, more than other ethers. An epoxide is a cyclic ether that contains a three atom ring that comes close to an equilateral triangle. The primary structure of an epoxide contains two carbon atoms and a hydrocarbon attached to an oxygen atom. It polymerizes in the presence of catalysts or when heated. It’s hydrophilic, very flammable and easily ignited by heat or sparks.

Methacrylonitrile, MeAN in short, is a chemical compound that is an unsaturated aliphatic nitrile, widely used in the preparation of homopolymers, copolymers, elastomers, and plastics and as a chemical intermediate in the preparation of acids, amides, amines, esters, and other nitriles. MeAN is also used as a replacement for acrylonitrile in the manufacture of an acrylonitrile/butadiene/styrene-like polymer. It is a clear and colorless liquid, that has a bitter almond smell.

<span class="mw-page-title-main">Glycidamide</span> Chemical compound

Glycidamide is an organic compound with the formula H2NC(O)C2H3O. It is a colorless, oil. Structurally, it contains adjacent amides and epoxide functional groups. It is a bioactive, potentially toxic or even carcinogenic metabolite of acrylonitrile and acrylamide. It is a chiral molecule.

(+)-Benzo(<i>a</i>)pyrene-7,8-dihydrodiol-9,10-epoxide Cancer-causing agent derived from tobacco smoke

(+)-Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide is an organic compound with molecular formula C20H14O3. It is a metabolite and derivative of benzo[a]pyrene (found in tobacco smoke) as a result of oxidation to include hydroxyl and epoxide functionalities. (+)-Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide binds to the N2 atom of a guanine nucleobase in DNA, distorting the double helix structure by intercalation of the pyrene moiety between base pairs through π-stacking. The carcinogenic properties of tobacco smoking are attributed in part to this compound binding and inactivating the tumor suppression ability of certain genes, leading to genetic mutations and potentially to cancer.

References

  1. Merck Index (11th ed.). 8287.
  2. Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-15.
  3. 1 2 Kamdem, Donatien; Gage, Douglas (2007). "Chemical Composition of Essential Oil from the Root Bark of Sassafras albidum". Planta Medica. 61 (6): 574–5. doi:10.1055/s-2006-959379. PMID   8824955.
  4. 1 2 Hickey, Michael J. (1948). "Investigation of the chemical constituents of Brazilian sassafras oil". Journal of Organic Chemistry. 13 (3): 443–6. doi:10.1021/jo01161a020. PMID   18863852.
  5. The history of research on safrole appears in: Semmler, F.W. (1907). Die Ätherischen Öle nach ihren chemischen Bestandteilen unter Berücksichtigung der geschichtlichen Entwicklung [The volatile oils according to their chemical components with regard to their historical development] (in German). Vol. 4. Leipzig, Germany: Veit & Co. pp. 139–144.
  6. [http://facultes19.ish-lyon.cnrs.fr/fiche.php?indice=456 Les professeurs des facultés des lettres et des sciences en france au xixe siècle (1808-1880)
  7. Saint-Èvre (1844). "Recherches sur l'huile essentielle de sassafras" [Investigations of the essential oil of sassafras]. Annales de Chimie et de Physique. 3rd series (in French). 12: 107–113.; see p. 108.
  8. Grimaux, E; Ruotte, J. (1869). "Sur l'essence de sassafras" [On the essential oil of sassafras]. Comptes Rendus (in French). 68: 928–930. From p. 928: "Ils sont constitués par une principe oxygéné, la safrol C10H10O2 … " (They [the fractions of essential oil that are safrole] are composed of an oxygenated substance, safrole C10H10O2 … )
  9. (Grimaux & Ruotte, 1869), p. 929.
  10. Poleck, Theodor (1884). "Ueber die chemische Constitution des Safrols" [On the chemical composition of safrole]. Berichte der Deutschen Chemischen Gesellschaft. 17 (2): 1940–1944. doi:10.1002/cber.18840170278. See structural formula on p. 1941.
  11. Eijkman, J.F. (1885). "Sur les principes constituants de l'Illicium religiosum (Sieb.) (Shikimi-no-ki en japonais)" [On the substances composing Illicium religiosum (Sieb.) (Shikimi-no-ki in Japanese)]. Recueil des Travaux Chimiques des Pays-Bas (in French). 4 (2): 32–54. doi:10.1002/recl.18850040202.; see pp. 39–40.
  12. Fittig, Rud.; Remsen, Ira (1871). "Untersuchungen über die Constitution des Piperins und seiner Spaltungsproducte Piperinsäure und Piperidin" [Investigations into the composition of piperine and its cleavage products piperic acid and piperidine ]. Annalen der Chemie (in German). 159 (2): 129–158. doi:10.1002/jlac.18711590202.; see the structural formula for Piperonylsäure on p. 155.
  13. (Eijkman, 1885), pp. 40–41.
  14. (Eijkman, 1885), pp. 41–42.
  15. Poleck, Th. (1886). "Ueber die chemische Structur des Safrols" [On the chemical structure of safrole]. Berichte der Deutschen Chemischen Gesellschaft (in German). 19: 1094–1098. doi:10.1002/cber.188601901243.
  16. Brühl, J.W. (1888). "Untersuchungen über die Terpene und deren Abkömmlinge" [Investigations of the terpenes and their derivatives]. Berichte der Deutschen Chemischen Gesellschaft (in German). 21: 457–477. doi:10.1002/cber.18880210181.; see pp. 474–477.
  17. Harvey, John L. (December 2, 1960). "Refusal to Extend Effective Date of Statute for Certain Specified Food Additives" (PDF). Federal Register Archive. United States Food & Drug Administration. p. 12412. Retrieved November 28, 2022.
  18. Ledgard, J. (2010). Kings Chem Guide Second Edition.
  19. Perkin, William Henry; Trikojus, Victor Martin (1927). "CCXII.—A synthesis of safrole and o-safrole". Journal of the Chemical Society: 1663–1666. doi:10.1039/JR9270001663.
  20. Kamdem, Donatien; Gage, Douglas (1995-12-01). "Chemical Composition of Essential Oil from the Root Bark of Sassafras albidum". Planta Medica. 61 (6): 574–575. doi:10.1055/s-2006-959379. ISSN   0032-0943. PMID   8824955.
  21. Hickey, M. J. (1948-05-01). "Investigation of the chemical constituents of Brazilian sassafras oil". The Journal of Organic Chemistry. 13 (3): 443–446. doi:10.1021/jo01161a020. ISSN   0022-3263. PMID   18863852.
  22. Wisneski, Harris H.; Yates, Ronald L.; Davis, Henry M. (1983). "High-performance liquid chromatographic—fluorometric determination of safrole in perfume, cologne and toilet water". Journal of Chromatography A. 255: 455–461. doi:10.1016/s0021-9673(01)88300-x.
  23. 1 2 Hung, Shan-Ling; Chen, Yu-Ling; Chen, Yen-Ting (2003-04-01). "Effects of safrole on the defensive functions of human neutrophils". Journal of Periodontal Research. 38 (2): 130–134. doi:10.1034/j.1600-0765.2003.01652.x. ISSN   0022-3484. PMID   12608906.
  24. Zhao, Jing; Miao, Junying; Zhao, Baoxiang; Zhang, Shangli; Yin, Deling (2005-06-01). "Safrole oxide inhibits angiogenesis by inducing apoptosis". Vascular Pharmacology. 43 (1): 69–74. doi:10.1016/j.vph.2005.04.004. ISSN   1537-1891. PMID   15936989.
  25. Perkin, William Henry; Trikojus, Victor Martin (1927-01-01). "CCXII.—A synthesis of safrole and o-safrole". J. Chem. Soc.: 1663–1666. doi:10.1039/jr9270001663. ISSN   0368-1769.
  26. "Synthesis of Safrole - [www.rhodium.ws]". erowid.org. Retrieved 2017-04-27.
  27. Lima, P. C.; Lima, L. M.; da Silva, K. C.; Léda, P. H.; de Miranda, A. L.; Fraga, C. A.; Barreiro, E. J. (2000-02-01). "Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole". European Journal of Medicinal Chemistry. 35 (2): 187–203. doi:10.1016/s0223-5234(00)00120-3. ISSN   0223-5234. PMID   10758281.
  28. Lages, A. S.; Silva, K. C.; Miranda, A. L.; Fraga, C. A.; Barreiro, E. J. (1998-01-20). "Synthesis and pharmacological evaluation of new flosulide analogues, synthesized from natural safrole". Bioorganic & Medicinal Chemistry Letters. 8 (2): 183–188. doi:10.1016/s0960-894x(97)10216-5. ISSN   0960-894X. PMID   9871651.
  29. Lima, L.M.; Amarante, E.G.; Miranda, A.L.P.; Fraga, C.A.M.; Barreiro, E.J. (1999). "Synthesis and Antinociceptive Profile of Novel Acidic Sulphonylhydrazone Derivatives From Natural Safrole". Pharmacy and Pharmacology Communications. 5 (12): 673–678. doi:10.1211/146080899128734370.
  30. Fraga, Carlos A. M.; Barreiro, Eliezer J. (1992-10-01). "The synthesis of a new benzothiazine derivative, related to oxicams, synthesized from natural safrole". Journal of Heterocyclic Chemistry. 29 (6): 1667–1669. doi:10.1002/jhet.5570290652. ISSN   1943-5193.
  31. 1 2 3 Ioannides, C.; Delaforge, M.; Parke, D. V. (1981-10-01). "Safrole: its metabolism, carcinogenicity and interactions with cytochrome P-450". Food and Cosmetics Toxicology. 19 (5): 657–666. doi:10.1016/0015-6264(81)90518-6. ISSN   0015-6264. PMID   7030889.
  32. 1 2 3 4 Sekizawa, J.; Shibamoto, T. (1982-04-01). "Genotoxicity of safrole-related chemicals in microbial test systems". Mutation Research. 101 (2): 127–140. doi:10.1016/0165-1218(82)90003-9. ISSN   0027-5107. PMID   6808388.
  33. Jeurissen, Suzanne M. F.; Bogaards, Jan J. P.; Awad, Hanem M.; Boersma, Marelle G.; Brand, Walter; Fiamegos, Yiannis C.; van Beek, Teris A.; Alink, Gerrit M.; Sudhölter, Ernst J. R. (2004-09-01). "Human cytochrome p450 enzyme specificity for bioactivation of safrole to the proximate carcinogen 1'-hydroxysafrole". Chemical Research in Toxicology. 17 (9): 1245–1250. doi:10.1021/tx040001v. ISSN   0893-228X. PMID   15377158.
  34. MacFabe, Derrick F.; Cain, Donald P.; Rodriguez-Capote, Karina; Franklin, Andrew E.; Hoffman, Jennifer E.; Boon, Francis; Taylor, A. Roy; Kavaliers, Martin; Ossenkopp, Klaus-Peter (2007-01-10). "Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders". Behavioural Brain Research. Animal Models for Autism. 176 (1): 149–169. doi:10.1016/j.bbr.2006.07.025. PMID   16950524. S2CID   3054752.
  35. O'Mathuna, Donal (10 August 2010). "Does it work? Can sassafras be used as a general tonic?". Irish Times .
  36. Hagan, Ernest C.; Jenner, Paul M.; Jones, Wm.I.; Fitzhugh, O.Garth; Long, Eleanor L.; Brouwer, J.G.; Webb, Willis K. (1965). "Toxic properties of compounds related to safrole". Toxicology and Applied Pharmacology. 7 (1): 18–24. doi:10.1016/0041-008x(65)90069-4. PMID   14259070.
  37. Liu, T.Y.; Chen, C.C.; Chen, C.L.; Chi, C.W. (1999). "Safrole-induced Oxidative Damage in the Liver of Sprague–Dawley Rats". Food and Chemical Toxicology . 37 (7): 697–702. doi:10.1016/S0278-6915(99)00055-1. PMID   10496370.
  38. Benedetti, M; Malnoe, A; Broillet, A (1977). "Absorption, metabolism and excretion of safrole in the rat and man". Toxicology. 7 (1): 69–83. doi:10.1016/0300-483X(77)90039-7. PMID   14422.
  39. Opinion of the Scientific Committee on Food on the safety of the presence of safrole (1-allyl-3,4-methylenedioxybenzene) in flavourings and other food ingredients with flavouring properties
  40. "Ranking Possible Cancer Hazards on the HERP Index" (PDF). Retrieved 2013-10-22.
  41. Liu, T. Y.; Chen, C. C.; Chen, C. L.; Chi, C. W. (1999-07-01). "Safrole-induced Oxidative Damage in the Liver of Sprague–Dawley Rats". Food and Chemical Toxicology. 37 (7): 697–702. doi:10.1016/S0278-6915(99)00055-1. PMID   10496370.
  42. Su, Le; Zhao, BaoXiang; Lv, Xin; Wang, Nan; Zhao, Jing; Zhang, ShangLi; Miao, JunYing (2007-02-20). "Safrole oxide induces neuronal apoptosis through inhibition of integrin β4/SOD activity and elevation of ROS/NADPH oxidase activity". Life Sciences. 80 (11): 999–1006. doi:10.1016/j.lfs.2006.11.041. PMID   17188719.
  43. International Narcotics Control Board Archived 2008-02-27 at the Wayback Machine
  44. Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors
  45. The Merck Index , 13th edition, Merck & Co, Inc, Whitehorse Station, NJ, copyright 2001.
  46. Ledgard, Jared (2010). Kings Chem Guide (2nd ed.). UVKCHEM, Inc. p. 206. ISBN   9780578058658 . Retrieved 6 September 2014.
  47. Campbell, Sam (30 August 2009). "Harvested to make Ecstasy, Cambodia's trees are felled one by one". GlobalPost. Retrieved 2 September 2009.
  48. 1 2 Blickman, Tom (February 3, 2009). "Harvesting Trees to Make Ecstasy Drug". The Irrawaddy .
  49. 1 2 Rocha, Sérgio F.R.; Ming, Lin Chau (1999). "Piper hispidinervum: A Sustainable Source of Safrole". In Janick, Jules (ed.). Perspectives on new crops and new uses. Alexandria, Virginia: ASHS Press. pp. 479–81. ISBN   978-0-9615027-0-6.